Terms: = Leukemia AND HOXD13, SPD, 3239, P35453, HOX4I AND Prognosis
7 results:
1. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
[TBL] [Abstract] [Full Text] [Related]
2. Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas.
Zhang X; Liu L; Zhou S; Zhao K; Song Z; Hu G; Zhang T; Li Y; Qiu L; Li L; Qian Z; Meng B; Pan Y; Ren X; Wang X; Zhang H; Fu K
Hematol Oncol; 2019 Aug; 37(3):270-276. PubMed ID: 31074879
[TBL] [Abstract] [Full Text] [Related]
3. GFI1 as a novel prognostic and therapeutic factor for AML/MDS.
Hönes JM; Botezatu L; Helness A; Vadnais C; Vassen L; Robert F; Hergenhan SM; Thivakaran A; Schütte J; Al-Matary YS; Lams RF; Fraszscak J; Makishima H; Radivoyevitch T; Przychodzen B; da Conceição Castro SV; Görgens A; Giebel B; Klein-Hitpass L; Lennartz K; Heuser M; Thiede C; Ehninger G; Dührsen U; Maciejewski JP; Möröy T; Khandanpour C
Leukemia; 2016 Jun; 30(6):1237-45. PubMed ID: 26847026
[TBL] [Abstract] [Full Text] [Related]
4. High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.
Rossille D; Gressier M; Damotte D; Maucort-Boulch D; Pangault C; Semana G; Le Gouill S; Haioun C; Tarte K; Lamy T; Milpied N; Fest T; ;
Leukemia; 2014 Dec; 28(12):2367-75. PubMed ID: 24732592
[TBL] [Abstract] [Full Text] [Related]
5. Troxacitabine: BCH 4556, spd 758, Troxatyl.
Adis International Ltd
Drugs R D; 2003; 4(4):264-8. PubMed ID: 12848594
[TBL] [Abstract] [Full Text] [Related]
6. Erythrocyte spermine levels: a prognostic parameter in childhood common acute lymphoblastic leukemia.
Bergeron C; Bansard JY; Le Moine P; Bouet F; Goasguen JE; Moulinoux JP; Le Gall E; Catros-Quemener V
Leukemia; 1997 Jan; 11(1):31-6. PubMed ID: 9001415
[TBL] [Abstract] [Full Text] [Related]
7. Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
Hersh EM; Gutterman JU; Mavligit GM; McCredie KB; Burgess MA; Matthews A; Freireich EJ
J Clin Invest; 1974 Aug; 54(2):401-8. PubMed ID: 4527189
[TBL] [Abstract] [Full Text] [Related]
